Pharmidex are proud to be part of the recent publication on African Trypanosomiasis in Journal of Antimicrobial Agents

July 19, 2017

Pharmidex team are proud to present it's latest involvement on the recent publication on African Typanosomiasis

Pharmidex are proud to be part of the recent publication on African Trypanosomiasis in Journal of Antimicrobial Agents

The Pharmidex team are proud to present it's latest involvement on the recent publication on African Typanosomiasis which was published in the International journal of antimicrobial agents. Dose-dependent effect and pharmacokinetics of fexinidazole and its metabolites in a mouse model of human African trypanosomiasis - International Journal of Antimicrobial Agents Human African trypanosomiasis (HAT) is a neglected tropical disease, with a population of 70 million at risk. Current treatment options are limited.

In the search for new therapeutics, the repurposing of the broad-spectrum antiprotozoal drug fexinidazole has completed Phase III trials with the anticipation that it will be the first oral treatment for HAT.

For more information please see - https://www.sciencedirect.com/journal/international-journal-of-antimicrobial-agents

< Older Post

Newer Post >

🌟 Pharmidex at Swiss Biotech Day 2025! 🌟

April 30, 2025

We’re excited to share that Ash Alavijeh , our Head of Operations, will attend the Swiss Biotech Day 2025 on May 5–6 at the Congress Center Basel, Switzerland! 🔗 https://swissbiotechday.ch Ash looks forward to connecting with attendees to explore new collaborations and drive drug discovery and development forward. If you're in Basel, let's meet and discuss how we can advance the next wave of innovative therapies together.

🚀 Pharmidex at Making Pharmaceuticals - Co-located with Distributing Pharmaceuticals UK 2025! 🚀

April 28, 2025

We are pleased to announce that Martin Barrett , our Head of Business Development, will be attending the Making & Distributing Pharmaceuticals UK event on 29–30 April 2025 at the Coventry Building Society Arena! 🔗 ( https://lnkd.in/gd73pvE ) Martin would be delighted to meet with fellow attendees to discuss new collaboration opportunities and how we can work together to advance the development of innovative drug candidates. If you are attending, don’t miss the chance to connect with us and explore how we can drive pharmaceutical progress forward together!

🤝 Pharmidex at the Biotech Matchmaking Event! 🤝

April 28, 2025

We’re excited that Ash Alavijeh , our Head of Operations, will attend the Biotech Matchmaking Event on 29 April 2025 at the Old Divinity School, St John’s College, Cambridge. 🔗 (Biotech Matchmaking Event - The Milner Therapeutics Institute) Ash looks forward to meeting attendees, discussing new collaborations, and driving forward the development of innovative drug candidates. If you're attending, let’s connect and explore new opportunities together!